Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial.

Cardiovasc Diabetol · 2019 · PMC6858725 · PMID 31733647

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significancep = 0.06so close (0.05 < p ≤ 0.1)

The difference in absolute change between the two groups showed a borderline significance ( p = 0.06).

also in 7,017 other papers

borderline significantno p-value reported

The difference in absolute change between the groups showed borderline significant (Fig. 1 f).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.